Stockscreener 앱 받기
1.68
15.86%
0.23
전일 마감가:
$1.45
열려 있는:
$1.37
하루 거래량:
1.51M
Relative Volume:
5.09
시가총액:
$201.95M
수익:
-
순이익/손실:
$-13.73M
주가수익비율:
-12.92
EPS:
-0.13
순현금흐름:
$-3.92M
1주 성능:
+17.48%
1개월 성능:
+8.39%
6개월 성능:
+12.00%
1년 성능:
+121.05%
1일 변동 폭
$1.36
$1.75
1주일 범위
$1.32
$1.75
52주 변동 폭
$0.6302
$2.60
Tiziana Life Sciences Ltd Stock (TLSA) Company Profile
TLSA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TLSA
Tiziana Life Sciences Ltd
|
1.68 | 174.30M | 0 | -13.73M | -3.92M | -0.13 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Tiziana Life Sciences Ltd Stock (TLSA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-12-22 | 개시 | B. Riley Securities | Buy |
| 2018-12-17 | 개시 | Laidlaw | Buy |
Tiziana Life Sciences Ltd 주식(TLSA)의 최신 뉴스
History Review: Can Tiziana Life Sciences Ltd sustain earnings growthEarnings Risk Summary & High Accuracy Trade Alerts - baoquankhu1.vn
Guidance Update: Is Tiziana Life Sciences Ltd likely to announce a buybackPortfolio Growth Summary & Free Safe Entry Trade Signal Reports - baoquankhu1.vn
Tiziana Life Sciences closes $8.8 million registered direct offering By Investing.com - Investing.com Nigeria
Orrick Advises Tiziana Life Sciences on Nasdaq Registered Direct Offering of Up to Approximately $17.6 Million - orrick.com
Tiziana Life Sciences Closes $8.8 Million Direct Offering of 7.04 Million Shares - Intellectia AI
Tiziana Life Sciences Raises $8.8 Million in Oversubscribed Direct Offering to Fund Phase 2 Trials - TipRanks
Tiziana Life Sciences announces closing of oversubscribed $8.8M offering - Proactive financial news
Tiziana Life Sciences closes $8.8 million registered direct offering - Investing.com
Tiziana Life Sciences Announces Closing of Oversubscribed $8.8 Million Registered Direct Offering of Ordinary Shares - Benzinga
Tiziana leaders invest in $8.8M raise to finish Phase 2 na-SPMS, MSA trials - Stock Titan
Volatility Watch: What is Verastem Incs P E ratio telling usJuly 2025 Setups & Safe Entry Point Alerts - baoquankhu1.vn
Small cap wrap: Nextech3D.ai, Aftermath Silver, Tiziana Life Sciences, AtaiBeckley… - Proactive financial news
Tiziana Life Sciences unveils registered direct offering of up to $17.6M - Proactive financial news
Tiziana Life Sciences Raises Up to $17.6 Million in Insider-Led Direct Offering to Fund Phase 2 Trials - TipRanks
Tiziana Life Sciences Announces $8 Million Registered Direct Offering of Ordinary Shares to Support Clinical Trials - Quiver Quantitative
CEO backs $17.6M Tiziana raise to fund key na-SPMS and MSA trials - Stock Titan
Layoff Watch: How Tiziana Life Sciences Ltd stock reacts to oil pricesJuly 2025 Movers & Safe Entry Momentum Stock Tips - Bộ Nội Vụ
Aug Ideas: Is Tiziana Life Sciences Ltd stock gaining market share2025 Top Gainers & Weekly Breakout Watchlists - Bộ Nội Vụ
Tiziana Life Sciences to Showcase Intranasal Foralumab at Neuroscience Innovation Forum During JPM Week - TipRanks
US Stocks Recap: Can Columbia Sportswear Company stock sustain revenue growthJuly 2025 Technicals & Target Return Focused Stock Picks - moha.gov.vn
Tiziana Life Sciences to Present at the 9th Annual Neuroscience Innovation Forum During J.P. Morgan Healthcare Conference Week in San Francisco - 富途牛牛
AIM ImmunoTech, PepGen, Aeon, Tiziana, Moleculin: 5 Biotech Stocks That Led Retail Message Growth Last Week - MSN
Tiziana Life Sciences Shares Drop After Company Unveils Plan to Spin Out IL-6 Program - MSN
Tiziana Life Sciences to present at 9th Annual Neurosciences Innovation Forum - Proactive financial news
Townhall - FinancialContent
Why Tiziana Life Sciences Ltd stock is rated strong buyQuarterly Portfolio Review & Safe Swing Trade Setup Alerts - Улправда
Tiziana Life Sciences Ltd Share Price (TLSA.US) - London South East
Tiziana Life Sciences (NASDAQ:TLSA) Trading Up 7.4% – Still a Buy? - Defense World
Tiziana Life Sciences (NASDAQ:TLSA) Trading Up 7.4%Still a Buy? - MarketBeat
Tiziana Life Sciences Files Annual Safety Report for Intranasal Foralumab with FDA - marketscreener.com
Tiziana Life Sciences files annual safety report for intranasal foralumab - Yahoo Finance
Is Tiziana Life Sciences Ltd a good long term investmentSupport and Resistance Levels & Free Risk Assessment and Control - earlytimes.in
Tiziana Life Sciences submits annual safety report for intranasal foralumab to FDA - Proactive financial news
Tiziana Life Sciences Reports Positive Safety Profile for Intranasal Foralumab Following 37.4 Patient-Years of Exposure - Quiver Quantitative
Tiziana Files Annual Safety Report for Intranasal Foralumab with FDA - The Manila Times
Small cap wrap: Tiziana Life Sciences, 374Water, First Phosphate... - Proactive financial news
Operating expenses (excl. COGS) of Tiziana Life Sciences Ltd. – GETTEX:0RP - TradingView — Track All Markets
Tiziana Life Sciences begins dosing in Phase 2 Alzheimer’s trialICYMI - Proactive financial news
Tiziana Life Sciences Announces Acquisition of Shares by Executive Chairman - The Manila Times
Tiziana Life Sciences Chair Boosts Stake to 36% with December Share Purchase - TipRanks
How buybacks impact Tiziana Life Sciences Ltd stock valueRecession Risk & Reliable Breakout Stock Forecasts - Улправда
Tiziana Life Sciences chairman increases stake to over 36% By Investing.com - Investing.com South Africa
Tiziana Life Sciences (TLSA) Chairman Expands Stake in the Compa - GuruFocus
Tiziana Life Sciences executive chairman increases stake - Proactive financial news
Why Tiziana Life Sciences Ltd stock is considered a top pickWeekly Stock Summary & Daily Risk Controlled Trade Plans - Bölüm Sonu Canavarı
Tiziana Life Sciences Executive Chairman Gabriele Cerrone Acquires Additional Shares, Increasing Ownership to 36.08% - Quiver Quantitative
Tiziana Life Sciences chairman increases stake to over 36% - Investing.com
Biotech founder lifts personal stake to 36% with latest share buy - Stock Titan
Can Tiziana Life Sciences Ltd stock maintain operating marginsShort Setup & Free Weekly Chart Analysis and Trade Guides - Улправда
Is Tiziana Life Sciences Ltd stock a buy on dipsIPO Watch & Safe Entry Zone Tips - DonanımHaber
Is Tiziana Life Sciences Ltd stock gaining market share2025 Market Overview & Daily Volume Surge Signals - Улправда
Tiziana Life Sciences Ltd (TLSA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.73%
0.92%
자본화:
|
볼륨(24시간):